Immunovant (IMVT) Cash & Equivalents (2018 - 2026)
Immunovant (IMVT) posted Cash & Equivalents of $797.8 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 33.2% from $598.91 million a year earlier but down 11.6% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant's Cash & Equivalents came in at $902.11 million, up 26.4% from FY2025.
- Annual Cash & Equivalents has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 17.7% (FY2021 to FY2026).
- In prior fiscal years, Immunovant's Cash & Equivalents was $713.97 million in FY2025 (+12.4%), $635.37 million in FY2024 (+68.7%), $376.53 million in FY2023 (-23.8%) and $493.82 million in FY2022 (+23.4%).
- Quarterly Cash & Equivalents has run from a low of $269.93 million in fiscal Q2 2024 to a high of $994.53 million in fiscal Q3 2026 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last six quarters, with growth averaging 35.5% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q3 2026, with growth of 165.4%; the weakest was fiscal Q3 2025, with a decline of 45.8%.
- According to Business Quant data, Cash & Equivalents for the three prior fiscal quarters was $902.11 million (Q4 2026), $994.53 million (Q3 2026) and $521.9 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Immunovant | 6.94 Bn | 6.94 Bn | - | 797.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 797.80 Mn |
| Mar 31, 2026 | 902.11 Mn |
| Dec 31, 2025 | 994.53 Mn |
| Sep 30, 2025 | 521.90 Mn |
| Jun 30, 2025 | 598.91 Mn |
| Mar 31, 2025 | 713.97 Mn |
| Dec 31, 2024 | 374.70 Mn |
| Sep 30, 2024 | 472.94 Mn |
| Jun 30, 2024 | 560.01 Mn |
| Mar 31, 2024 | 635.37 Mn |
| Dec 31, 2023 | 690.94 Mn |
| Sep 30, 2023 | 269.93 Mn |
| Jun 30, 2023 | 330.00 Mn |
| Mar 31, 2023 | 376.53 Mn |
| Dec 31, 2022 | 432.61 Mn |
| Sep 30, 2022 | 405.80 Mn |
| Jun 30, 2022 | 427.21 Mn |
| Mar 31, 2022 | 493.82 Mn |
| Dec 31, 2021 | 527.00 Mn |
| Sep 30, 2021 | 559.00 Mn |
API Access
Immunovant Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();